Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIIP vs Injectable Insulin in Insulin-Naive Type 2 Diabetes
NCT00325364Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2006
- Primary completion
- May 2008
- Modality
- Biologic
- Countries
- 11
01
Overview
A Phase 3 trial of insulin human in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Apr 2006; status: completed.
02
Drugs
insulin human
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00325364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325364.